Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.681
+0.161 (10.57%)
Jun 6, 2025, 2:54 PM - Market open
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $19.02 million as of June 6, 2025. Its market cap has decreased by -49.29% in one year.
Market Cap
19.02M
Enterprise Value
3.45M
1-Year Change
-49.29%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $19.02M, a decrease of -58.48%. That is a compound annual growth rate of -9.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 17.20M | -38.13% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.46B |
| Johnson & Johnson | 372.53B |
| AbbVie | 336.18B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.47B |
| Abbott Laboratories | 232.89B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |